1. Jemal, A, Bray, F, Center, MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
Google Scholar | Crossref | Medline | ISI2. Londero, SC, Krogdahl, A, Bastholt, L, et al. Papillary thyroid carcinoma in Denmark, 1996-2008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort. Thyroid 2015;25:78–84.
Google Scholar | Crossref | Medline3. Grogan, RH, Kaplan, SP, Cao, H, et al. A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 2013;154:1436–1446. discussion 1446–1437.
Google Scholar | Crossref | Medline4. Rotstein, L . The role of lymphadenectomy in the management of papillary carcinoma of the thyroid. J Surg Oncol 2009;99:186–188.
Google Scholar | Crossref | Medline | ISI5. Cooper, DS, Doherty, GM, Haugen, BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–1214.
Google Scholar | Crossref | Medline | ISI6. Moon, WJ, Jung, SL, Lee, JH, et al. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology 2008;247:762–770.
Google Scholar | Crossref | Medline | ISI7. Tessler, FN, Middleton, WD, Grant, EG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol 2017;14:587–595.
Google Scholar | Crossref | Medline8. Cho, E, Kim, EK, Moon, HJ, et al. High suspicion US pattern on the ATA guidelines, not cytologic diagnosis, may be a predicting marker of lymph node metastasis in patients with classical papillary thyroid carcinoma. Am J Surg 2018;216:562–566.
Google Scholar | Crossref | Medline9. Park, VY, Kim, EK, Moon, HJ, et al. The thyroid imaging reporting and data system on US, but not the BRAFV600E mutation in fine-needle aspirates, is associated with lateral lymph node metastasis in PTC. Medicine (Baltimore) 2016;95:e4292.
Google Scholar | Crossref | Medline10. Kim, SY, Kwak, JY, Kim, EK, et al. Association of preoperative US features and recurrence in patients with classic papillary thyroid carcinoma. Radiology 2015;277:574–583.
Google Scholar | Crossref | Medline11. Jianming, L, Jibin, L, Linxue, Q. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: significant role of HBME-1. Eur J Radiol 2020;123:108801.
Google Scholar | Crossref | Medline12. Kwak, JY, Han, KH, Yoon, JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 2011;260:892–899.
Google Scholar | Crossref | Medline | ISI13. Xu, SY, Yao, JJ, Zhou, W, et al. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion. Head Neck 2019;41:3984–3991.
Google Scholar | Crossref | Medline14. Roh, JL, Kim, JM, Park, CI. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol 2011;18:2245–2250.
Google Scholar | Crossref | Medline | ISI15. Podnos, YD, Smith, D, Wagman, LD, et al. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 2005;71:731–734.
Google Scholar | SAGE Journals | ISI16. Ito, Y, Miyauchi, A, Kihara, M, et al. Airtight tracheocutaneostomy after window resection of the trachea for invasive papillary thyroid carcinoma: experience of 109 cases. World J Surg 2014;38:660–666.
Google Scholar | Crossref | Medline17. Lim, YC, Liu, L, Chang, JW, et al. Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis. Oral Oncol 2016;62:109–113.
Google Scholar | Crossref | Medline18. Nie, X, Tan, Z, Ge, M, et al. Risk factors analyses for lateral lymph node metastases in papillary thyroid carcinomas: a retrospective study of 356 patients. Arch Endocrinol Metab 2016;60:492–499.
Google Scholar | Crossref | Medline19. Lim, YS, Lee, JC, Lee, YS, et al. Lateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasis. Surgery 2011;150:116–121.
Google Scholar | Crossref | Medline | ISI20. Sun, Y, Lv, H, Zhang, S, et al. Gender-specific risk of central compartment lymph node metastasis in papillary thyroid carcinoma. Int J Endocrinol 2018;2018:6710326.
Google Scholar | Crossref | Medline21. Tang, T, Li, J, Zheng, L, et al. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: a retrospective cohort study. Int J Surg 2018;54:129–132.
Google Scholar | Crossref | Medline22. Konturek, A, Barczyński, M, Nowak, W, et al. Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis. Langenbecks Arch Surg 2014;399:229–236.
Google Scholar | Crossref | Medline23. Qu, N, Zhang, L, Lin, DZ, et al. The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma. Tumour Biol 2016;37:7685–7692.
Google Scholar | Crossref | Medline24. Jeong, JS, Kim, HK, Lee, CR, et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. J Korean Med Sci 2012;27:883–889.
Google Scholar | Crossref | Medline25. Zeng, RC, Jin, LP, Chen, ED, et al. Potential relationship between Hashimoto’s thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer. Head Neck 2016;38:E1019–E1025.
Google Scholar | Crossref | Medline